Delivery Order SPE2DB20D1100-SPE2DB25FB9T5

Award Date 4/28/25
Potential Completion Date 4/29/25
Potential Value $2.3K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of 4,568,043,370 units of Jardiance 10 mg tablets, a diabetes medication, with a ceiling value of $12,577.82. The contract is a firm fixed-price, non-set-aside award with an ultimate completion date of April 28, 2025. AmerisourceBergen Drug Corp holds a significant Indefinite Delivery...
This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract, valued at $9,876.74, is for the delivery of 4,567,957,360 units of the diabetes medication Jardiance 25 mg tablets. The contract has an ultimate completion date of April 18, 2025 and is not set aside for a specific business type. AmerisourceBergen Drug Corp holds a substantial Indefinite Delivery Contract (IDC) with the DLA...
This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $13,369.07, is for the delivery of 4,568,077,683 units of the diabetes medication Jardiance 10 mg tablets. The contract has an ultimate completion date of April 30, 2025 and is not designated as a set-aside. AmerisourceBergen Drug Corp holds a significant $999,999,999.00 Indefinite...
This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract, valued at $5,931.70, is for the delivery of 4,567,874,185 units of the diabetes medication Jardiance 10 mg tablets. The award has an ultimate completion date of April 11, 2025 and is not designated as a set-aside contract. AmerisourceBergen Drug Corp holds a significant $999,999,999.00 Indefinite Delivery Contract (IDC) with the...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp's Corporate Office division. The order is for the supply of 4,566,100,466 units of the pharmaceutical drug Jardiance 10 mg tablets in 90-count packages. The contract has a firm-fixed price of $1,720.74 and a completion date of October 16, 2024. This delivery order is part of a larger Indefinite Delivery Contract (IDC) valued at up to $999,999,999 through December 2025, which enables DLA Troop...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corporation, a major pharmaceutical distributor. The contract is for the delivery of 4,565,634,277 units of the medication Jardiance 25 mg tablets in packages of 90. The contract has a ceiling value of $4,139.99 and an ultimate completion date of August 30, 2024. It is a Firm Fixed Price contract with no set-aside designation. AmerisourceBergen holds several...
This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of 4,567,996,072 units of the diabetes medication Jardiance 25 mg tablets. The contract has a ceiling value of $25,342.73 and a period of performance through April 23, 2025. This delivery order is part of a larger $999,999,999.00 Indefinite Delivery Contract (IDC) held by AmerisourceBergen with the DLA Troop Support Medical,...
This is a firm fixed-price delivery order issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is valued at $38,548.22 and has an ultimate completion date of April 30, 2025. It is for the provision of 4,568,076,618 units of the diabetes medication Jardiance 25 mg tablet in 90-count packages. The contract is not set-aside and represents an open competition award. AmerisourceBergen Drug...
This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of 4,567,870,676 units of Jardiance 10 mg tablets, a diabetes medication, with a ceiling value of $6,268.75. The contract has an ultimate completion date of April 11, 2025 and was awarded on April 10, 2025. This delivery order is part of a larger Indefinite Delivery Contract...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of Jardiance 25 mg tablets, a medication used to manage diabetes. The contract has a firm fixed price of $42,053.35 and a completion date of March 22, 2023. Amerisourcebergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as...
  • SPE2DB20D1100
    Indefinite Delivery Contract
  • SPE2DB20D1100-SPE2DB25FB9T5
    Delivery Order

This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of 4,568,057,960 units of the diabetes medication Jardiance 10 mg tablets in 90-count packages. The contract has a firm fixed price of $2,334.45 and a completion date of April 29, 2025. AmerisourceBergen Drug Corp holds a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999.00, which provides a comprehensive global pharmaceutical support vehicle through December 2026. This delivery order is not designated as a set-aside contract, indicating open competition. The contract supports the DLA's mission of providing medical supplies and pharmaceuticals to the U.S. military and other government agencies.

Generated 7/28/25, 11:16 AM